Skip to content
About
IIH
Intranasal Delivery
Pipeline
Intellectual Property
Contact
About
IIH
Intranasal Delivery
Pipeline
Intellectual Property
Contact
Idiopathic Intracranial Hypertension
Cluster Headaches
Idiopathic Intracranial Hypertension
Cluster Headaches
Idiopathic Intracranial Hypertension
2023
Completed
IN CNS rat exposure studies
2024
Completed
IN CNS 3-month rat toxicology study
2025
Completed
IN CNS 14-day maximum tolerated dose canine toxicology study
Completed
IN CNS 3-month canine toxicology study
Completed
IN Phase 1 PK, dose, and safety clinical trial in 20-healthy subjects
2026
To be initiated
IN Phase 2a open label 1-month safety and efficacy clinical trial in 18 IIH patients – estimated completion Q3
